左肾静脉支架植入术治疗胡桃夹综合征的临床疗效  

Stent implantation in the left renal vein for treatment of Nutcracker syndrome

作　　者：李承志[1] 张艳[1] 张红[1] 乔宏宇[1] 洪晓涛[1] 王晓白[1] 

机构地区：[1]暨南大学附属第一医院介入与血管外科,广东广州510632

出　　处：《中国介入影像与治疗学》2013年第7期389-392,共4页Chinese Journal of Interventional Imaging and Therapy

摘　　要：目的分析支架植入术治疗胡桃夹综合征(NCS)的安全性及临床疗效,探讨国人左肾静脉支架的选用标准。方法选取接受腔内支架植入术治疗的NCS患者36例,对其临床资料进行回顾性分析。术后随访12～98个月(中位随访时间53.5个月)。结果本组技术成功率100%,向各确诊NCS者左肾静脉植入14/60mm支架1枚,无围术期严重并发症发生。术后3个月,NCS相关临床症状几乎全部消失。随访期间全部支架通畅,无支架内再狭窄及临床症状复发;2例左肾静脉内支架发生移位,但无不良事件发生。结论左肾静脉腔内支架植入术治疗NCS安全有效且微创。治疗国人NCS时,在满足形态学测量的前提下,推荐首先选择14/60mm支架。Objective To evaluate the safety and clinical efficacy of stent implantation in patients with nutcracker syndrome（NCS）,and to explore the size selection of stent in the left renal vein of Chinese patients with NCS.Methods Thirty-six NCS patients who received stent implantation were collected,and the clinical data were retrospectively analyzed.The follow-up ranged from 12 to 98 months（median 53.5 months）.Results The technical success rate of interventional operation was 100%.NCS was confirmed and treated with implantation of a 14/60 mm stent in the left renal vein in all 36 patients.No serious perioperative complication occurred.NCS related clinical symptoms almost disappeared after 3 months.During the follow-up,stent displacement was observed in 2 patients,but no adverse events occurred.And all stents were patent during the follow-up without in-stent restenosis nor clinical symptoms recurrence.Conclusion Left renal vein stent implantation for the treatment of NCS is safe,effective and minimally invasive.For the treatment of Chinese NCS patents,in the premise to meet the morphological measurement,a 14/60 mm stent is recommended for the first consideration.

关 键 词：胡桃夹综合征 长期随访 腔内治疗 临床疗效 

分 类 号：R692.9[医药卫生—泌尿科学]